LDLR and neoplasm: Mechanistic investigations revealed that probiotic administration not only counteracts LDLR deficiency-driven colorectal carcinogenesis through gut microbiota remodeling, but also suppresses programmed death-ligand 1 (PD-L1) expression via cholesterol metabolic regulation, thereby reprogramming the tumor immune microenvironment.